Kalypsys vs Novalix

Kalypsys logo

Kalypsys

Shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas

est. 2001

VS
Novalix logo

Novalix

Novalix is a premier drug discovery CRO

371 employees · est. 2002 · Strasbourg, France

Kalypsys is the older company (2001 vs 2002).

Side-by-Side Comparison

Kalypsys Novalix
Founded
2001 older 2002
Headquarters
Not tracked yet Strasbourg, France
Employees
Not tracked yet 371
Industry
Biotechnology, Health and Wellness Biotechnology
Funding Stage
Series C Corporate Round
Total Funding
$171.00M $2.00M
Funding Rounds
3 2
Services
Not tracked yet Drug discovery, pharmacology, biophysics, chemistry, cosmetics, consulting services, technical services
Target Customers
Not tracked yet Biotech firms, pharmaceutical companies, research and development departments, clinical development teams
Taxonomy
Drug DiscoveryDrug DevelopmentTherapeutic AreasAutomated TechnologiesPathway-basedBiology +4 Drug DiscoveryBiophysical TechnologiesOutsourcingSPR TechnologyX-ray Protein CrystallographyNMR Technologies +9
Website
kalypsys.com novalix.com
Kalypsys logo

About Kalypsys

Kalypsys is a biotechnology company founded in 2001 that is focused on shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeutic areas. The company's slogan reflects its commitment to leveraging pathway-based drug discovery an...

Novalix logo

About Novalix

Novalix is a premier drug discovery CRO providing services to biotech firms and pharmaceutical companies. The company, founded in 2002, emphasizes the significance of exceptional scientific talent and exclusive resources, offering a range of platforms to improve the success rate during pre-clinical...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Kalypsys and Novalix for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Kalypsys or Novalix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Kalypsys was founded in 2001. Kalypsys is a biotechnology company founded in 2001 that is focused on shaping the future of medicine through comprehensive, automated drug discovery and development services across multiple therapeut. Novalix was founded in 2002, based in Strasbourg, France, with 371 employees. Novalix is a premier drug discovery CRO providing services to biotech firms and pharmaceutical companies. The company, founded in 2002, emphasizes the significance of exceptional scientific talent and.
Kalypsys has raised $171.00M and Novalix $2.00M. Latest stage: Kalypsys Series C, Novalix Corporate Round.
Both work in Biotechnology and list drug discovery among their focus areas.

Compare Kalypsys with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Kalypsys on 11 Sep 2024, and Novalix on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes